Stocks and Investing Stocks and Investing
Fri, March 5, 2021
Thu, March 4, 2021

Gbola Amusa Maintained (TSHA) at Strong Buy with Increased Target to $60 on, Mar 4th, 2021


Published on 2024-10-27 15:51:11 - WOPRAI, Gbola Amusa
  Print publication without navigation


Gbola Amusa of Chardan Capital, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy with Increased Target from $45 to $60 on, Mar 4th, 2021.

Gbola has made no other calls on TSHA in the last 4 months.



There are 2 other peers that have a rating on TSHA. Out of the 2 peers that are also analyzing TSHA, 0 agree with Gbola's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Gbola


  • Raju Prasad of "William Blair" Initiated at Buy and Held Target at $46 on, Wednesday, February 24th, 2021
  • Kevin DeGeeter of "Oppenheimer" Initiated at Buy on, Tuesday, January 5th, 2021
Contributing Sources